Product Description
Overall, the global biceps tenodesis market was valued at $120 million in 2022. This is expected to increase over the forecast period at a CAGR of 4.4% to reach $162.8 million.
The full report suite on the global market for biceps tenodesis includes suture anchors and tenodesis screws.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2029, and Historical Data to 2019
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Procedure Volumes
- Company Profiles, Product Portfolios and SWOT for Top Competitors
- COVID-19 Impact Analysis
PROCEDURE NUMBERS
Biceps can be repaired via tenodesis or tenotomy. Tenodesis cuts and reattaches the tendon with a screw or suture anchor. Tenotomy detaches the tendon, causing strength loss and the “Popeye” effect. Tenotomy is simpler but less effective than repair surgery and can be done with other procedures. Biceps tenodesis procedures will moderately increase in number over time.
GLOBAL BICEPS TENODESIS MARKET TRENDS
New clinical evidence shows that tenodesis is more effective than tenotomy. Both procedures have similar functional outcomes, but tenotomy has a higher risk of cosmetic deformity (known as the “Popeye” effect) compared to tenodesis. This has led to a shift towards using tenodesis devices for bicep tendon repairs, driving market growth.
GLOBAL BICEPS TENODESIS MARKET SHARE INSIGHTS
Overall, within the global biceps tenodesis market there are three dominant competitors: Arthrex, Smith & Nephew, and DePuy Synthes.In 2022, Arthrex was the leader of the biceps tenodesis repair market, holding over a third of the total market share. Arthrex sells a line of tenodesis implants under the SwiveLock® brand, designed specifically for biceps tenodesis and available in suture eyelets or closed eyelets configurations.
GLOBAL BICEPS TENODESIS MARKET SEGMENTATION SUMMARY
- Suture Anchor Market
- Tenodesis Screws Market
Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2022 |
Forecast Period | 2023-2029 |
Historical Data | 2019-2022 |
Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.